Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Activation-induced CD154 expression abrogates tolerance induced by apoptotic cellsPrajwal Gurung, Tamara A Kucaba, Thomas A Ferguson, et al.
Journal of Leukocyte Biology|September 3, 2010
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletionPrajwal Gurung, Tamara A Kucaba, Stephen P Schoenberger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cellsThomas S Griffith, Erik L Brincks, Prajwal Gurung, et al.
Chemical Immunology and Allergy|February 1, 2007
The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune responseThomas A Ferguson, Thomas S Griffith
Immunological Reviews|September 16, 2006
A vision of cell death: Fas ligand and immune privilege 10 years laterThomas A Ferguson, Thomas S Griffith
Immunity|November 1, 2011
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cellsThomas S Griffith, Thomas A Ferguson
Cancer Immunology, Immunotherapy : CII|April 9, 2014
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cellsBritnie R James, Erik L Brincks, Tamara A Kucaba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
CD8 T cells utilize TRAIL to control influenza virus infectionErik L Brincks, Arna Katewa, Tamara A Kucaba, et al.
Nanoscale|November 8, 2018
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapyHyunjoon Kim, Drishti Sehgal, Tamara A Kucaba, et al.
Pageof 28